SignalHF vs IM007

When choosing between SignalHF and IM007, cardiologists should consider their primary need: predictive analytics for heart failure or a comprehensive remote monitoring platform. SignalHF is specifically designed as an FDA-cleared AI algorithm focused on predicting heart failure hospitalizations within 30 days. It excels at analyzing data from various cardiac implantable electronic devices (CIEDs) to provide early alerts and facilitate personalized care plans, making it ideal for practices prioritizing proactive heart failure management and intervention based on predictive risk scores.

In contrast, IM007 is a broader, FDA-cleared, AI-powered cloud-based platform for remote cardiac monitoring. While it incorporates SignalHF as one of its features, IM007’s core strength lies in aggregating data from all CIEDs to streamline workflows, reduce false alerts through AI-driven alert management (e.g., for ILR ECG and AF alerts), and automate various tasks like billing and reporting. Physicians seeking a unified platform to manage and optimize their entire remote cardiac monitoring operations, including data aggregation, workflow automation, and alert reduction across a diverse patient population with various CIEDs, would find IM007 more suitable.

Therefore, a physician whose primary goal is to leverage predictive AI for early heart failure intervention should opt for SignalHF. However, if the objective is to implement a robust, all-encompassing remote cardiac monitoring solution that integrates data, automates workflows, and intelligently manages alerts from all CIEDs, then IM007 would be the more appropriate choice, as it offers a wider array of features beyond just heart failure prediction.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist